Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Are Medical Stocks Lagging Bayer (BAYRY) This Year?
10:46am, Wednesday, 09'th Apr 2025
Here is how Bayer Aktiengesellschaft (BAYRY) and Lonza Group Ag (LZAGY) have performed compared to their sector so far this year.
Bayer renews bid for US Supreme Court to curb glyphosate cases
03:07pm, Friday, 04'th Apr 2025
Bayer said on Friday it was again petitioning the U.S. Supreme Court to sharply limit legal claims that its Roundup weedkiller causes cancer, seeking to avoid potentially billions of dollars in damage
Bayer announces filing of petition to U.S. Supreme Court for review of Durnell Roundup™ case
03:00pm, Friday, 04'th Apr 2025
LEVERKUSEN, Germany--(BUSINESS WIRE)--Today Bayer – through its indirect subsidiary Monsanto – filed its petition for a writ of certiorari with the U.S. Supreme Court in the Durnell case, just thr
Bayer's Vividion Initiates Dosing in Early-Stage Cancer Study
02:45pm, Friday, 04'th Apr 2025
BAYRY subsidiary Vividion Therapeutics doses the first patient in a phase I study on VVD-159642 to treat advanced solid tumors.
FMC & Bayer Partner to Bring Isoflex Active to European Markets
01:40pm, Wednesday, 02'nd Apr 2025
FMC signed a partnership agreement to bring Isoflex Active technology to European markets.
Bayer eyes launch of menopause relief, heart drugs this year
07:01am, Tuesday, 01'st Apr 2025
Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of at least $1 billion, as it seeks to strengthen its pharmaceuticals business
Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharma
01:40pm, Thursday, 27'th Mar 2025
Bayer obtains an exclusive worldwide license for MTA-cooperative PRMT5 inhibitor from Suzhou Puhe BioPharma for selective targeting of MTAP-deleted tumors.
Bayer (BAYRY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
10:55am, Wednesday, 26'th Mar 2025
Bayer (BAYRY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall St
Bayer acquires rights in Puhe BioPharma cancer drug candidate
03:57am, Wednesday, 26'th Mar 2025
Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with China's Puhe BioPharma.
Bayer Down on Verdict to Pay $2.1B to Plaintiff in Roundup Litigation
04:00pm, Tuesday, 25'th Mar 2025
BAYRY suffers a setback after the jury at the Barnes Roundup trial in the State Court of Cobb County, Georgia, reached a verdict in favor of the plaintiff. Stock declines.
5 Large Drug Stocks to Watch as Industry Recovers
07:50am, Tuesday, 25'th Mar 2025
Industry Description
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from 13 new analyses from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the American Col
Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case
01:25pm, Monday, 24'th Mar 2025
Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged cancer risk tied to its Roundup weed killer, sending shares of the German
Is Bayer (BAYRY) Stock Outpacing Its Medical Peers This Year?
10:46am, Monday, 24'th Mar 2025
Here is how Bayer Aktiengesellschaft (BAYRY) and Enhabit (EHAB) have performed compared to their sector so far this year.
Dr. Mike Graham Appointed as New Head of R&D for Bayer's Crop Science Division
09:04am, Monday, 24'th Mar 2025
MONHEIM, Germany--(BUSINESS WIRE)--Bayer announced today that Dr. Mike Graham will become the new Head of Research & Development (R&D) for Bayer's Crop Science division and serve as member of the Lead
